Abstract
Clostridium difficile (C.diff) is a gram positive-spore forming anaerobic bacteria that forms colitis through the disruption of the gut flora after the consumption of antibiotics. The infection is associated with high morbidity and mortality. In order to reduce the incidence of C.diff the health board suggested the reduction of 4C antibiotics, however not in every case it is possible to avoid the antibiotic prescription.
Original language | English |
---|---|
Number of pages | 1 |
Publication status | Published - 21 May 2018 |
Event | Farr PhD Symposium and Innovation Workshop - The Studio, Manchester, United Kingdom Duration: 21 May 2018 → 22 May 2018 http://www.farrinstitute.org/events-courses/event/the-farr-institute-phd-and-early-career-researcher-symposium |
Workshop
Workshop | Farr PhD Symposium and Innovation Workshop |
---|---|
Country/Territory | United Kingdom |
City | Manchester |
Period | 21/05/18 → 22/05/18 |
Internet address |
Keywords
- clostridium difficile
- risk prediction
- risk management